HealthQuill ADHD
Drugs Health

FDA’s caution to physicians about autism-Tylenol link fuels debate

HQ Team September 23, 2025: The U.S. Food and Drug Administration (FDA) has recently issued a cautionary note regarding the use of acetaminophen.

Read More
Artificial intelligence platforms for psychiatric patients are showing a pattern of racial bias by proposing different treatments for people of colour, a small Cedars-Sinai study finds.
Health Medical Research

AI platforms for psychiatric patients show racial bias: Cedars-Sinai

HQ Team July 17, 2025: Artificial intelligence platforms for psychiatric patients are showing a pattern of racial bias by proposing different treatments for.

Read More
A majority of clinical research on adult Attention Deficit Hyperactivity Disorder (ADHD) suffers from serious methodological shortcomings, making it difficult to use the results in practice, according to researchers from the University of Copenhagen and the University of SĂŁo Paulo.
Drugs Health Research

Researchers find serious flaws in clinical trials with adult ADHD patients

HQ Team July 2, 2025: A majority of clinical research on adult Attention Deficit Hyperactivity Disorder (ADHD) suffers from serious methodological shortcomings, making.

Read More
Excessive levels of parental involvement and control stem from a worry that their child may come to harm or not do well enough.
Health Research

Rising childhood mental health issues linked to caregiver well-being

HQ Team February 18, 2025: A new study from Florida Atlantic University’s Schmidt College of Medicine reveals a troubling rise in childhood mental,.

Read More
US adults with attention deficit hyperactivity disorder (ADHD) rose from 10.6% to 15.2% between 2020 and 2023, and Covid-19 pandemic may be a major factor, according to a study published in Psychiatric Research and Clinical Practice.
Health Medical Research

ADHD in US adults rises to 15.2% between 2020 and 2023: Research

US adults with attention deficit hyperactivity disorder (ADHD) rose from 10.6% to 15.2% between 2020 and 2023, and Covid-19 pandemic may be a.

Read More
Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression after five years, according to company data.
Health Uncategorized

Review finds links between allergic diseases and mental health conditions

HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive.

Read More
depression
Drugs Health Pharma

High doses of ADHD drugs linked to increased risk of psychosis

HQ Team September 14, 2024: High doses of Attention Deficit and Hyperactivity Disorder (ADHD) medicines can lead to a greater risk of developing.

Read More
Dementia, Behavioural Disorders, ADHD
Drugs Health Opinion Pharma

Opinion: Proxy parenting not ideal, leads to depression, anxiety in children 

The phrase "It takes a village to raise a child" emphasizes the importance of children interacting with diverse individuals beyond their immediate family..

Read More
Drugs Health Pharma

Energy drinks linked to ADHD, anxiety among youth: Study

HQ Team January 20, 2024: Energy drinks have become increasingly popular among teenagers, with over 30% of teens aged 12–17 regularly consuming these.

Read More
Takeda Pharmaceutical’s subsidiary, Shire Plc., was granted an FDA nod for making generic chewable tablets to treat attention-deficit, hyperactivity disorder, and moderate to severe binge disorder in adults.
Drugs Health Pharma

First generic versions of Japan’s Takeda ADHD tabs gets FDA nod

HQ Team August 29, 2023: The US Food and Drug Administration has approved several first generics of Takeda Pharmaceutical subsidiary, Shire Plc’s Vyvanse.

Read More